• About us
• Contact

Advertisement

Organisation › Details

WuXi PharmaTech (Group)

The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. WuXi PharmaTech (NYSE: WX) is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customerfocused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. *

 

	Start	2000-12-01 established
	Industry	drug discovery
	Industry 2	chemical compound library (production)
	Region	Shanghai
	Country	China
	Street	288 Fute Zhong Road, Wai gaoqiao Free Trade Zone
	City	200131 Shanghai
	Tel	+86-21-5046-1111
		Address record changed: 2020-12-02
Basic data	Employees	F: 1,001 to 5,000 (2010-05-25)
		* Document for »About Section«:
		Record changed: 2024-08-24

Advertisement

More documents for WuXi PharmaTech (Group)

• [1] Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel....
• [2] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
• [3] Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development"....
• [4] Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY....
• [5] Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge....
• [6] WuXi AppTec. (7/20/21). Web Page: WuXi Global Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
• [7] WuXi AppTec. (7/20/21). Web Page: WuXi Healthcare Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
• [8] Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford....
• [9] Quanterix Corporation. (2/12/21). "Press Release: Quanterix Announces Simoa Joint Laboratory with WuXi AppTec". Billerica, MA....
• [10] Sphere Fluidics Ltd.. (2/18/19). "Press Release: Oxford Genetics and Sphere Fluidics Announce a Multi-partner Collaboration to Expedite the Development of Automated Microfluidic Systems for Rapid and High-throughput Gene Editing in Mammalian Cell Lines"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.